SEGALL BRYANT & HAMILL, LLC

Position in ANIP — Ani Pharmaceuticals Inc

CIK 1006378 CHICAGO, IL

Position in ANIP

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$2,720,150

+$41,416 QoQ

Shares Held

32,860

-5.7% QoQ

Ownership

0.143%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#95

of 303 holders

Holding Since

Jun 2024

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEGALL BRYANT & HAMILL, LLC holds $61,046,740 across 14 Drug Manufacturers - Specialty & Generic names. ANIP ranks #6 (4.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	498,222	$26,106,832
2	NBIX	Neurocrine Biosciences Inc	64,908	$10,939,594
3	KNSA	Kiniksa Pharmaceuticals International, plc	71,901	$4,598,068
4	AMRX	Amneal Pharmaceuticals, Inc.	240,060	$4,155,438
5	LQDA	Liquidia Corp	50,802	$4,050,443
6	ANIP	Ani Pharmaceuticals Inc This page	32,860	$2,720,150
7	IRWD	Ironwood Pharmaceuticals Inc	408,064	$1,717,949
8	SUPN	Supernus Pharmaceuticals, Inc.	25,931	$1,206,050

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,720,150	32,860	-5.7%	Shares	Sole	2026-08-12
2026-03-31	$2,678,734	34,834	-4.2%	Shares	Sole	2026-05-22
2025-12-31	$2,869,469	36,350	-1.8%	Shares	Sole	2026-02-13
2025-09-30	$3,390,848	37,018	-3.9%	Shares	Sole	2025-11-12
2025-06-30	$2,514,604	38,538	-6.9%	Shares	Sole	2025-08-12
2025-03-31	$2,772,734	41,415	-4.7%	Shares	Sole	2025-05-02
2024-12-31	$2,401,473	43,442	-3.2%	Shares	Sole	2025-02-11
2024-09-30	$2,677,063	44,872	+1.7%	Shares	Sole	2024-11-08
2024-06-30	$2,810,325	44,132	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.